Cargando…
Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
BACKGROUND: Aberrant activation of fibroblast growth factor receptors (FGFRs) deregulates cell proliferation and promotes cell survival, and may predispose to tumorigenesis. Therefore, selective inactivation of FGFRs is an important strategy for cancer therapy. Here as a proof-of-concept study, we d...
Autores principales: | Ling, Ling, Tan, Si Kee, Goh, Ting Hwee, Cheung, Edwin, Nurcombe, Victor, van Wijnen, Andre J., Cool, Simon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511971/ https://www.ncbi.nlm.nih.gov/pubmed/26201468 http://dx.doi.org/10.1186/s12943-015-0391-4 |
Ejemplares similares
-
Growth Differentiation Factor 5-Mediated Enhancement of Chondrocyte Phenotype Is Inhibited by Heparin: Implications for the Use of Heparin in the Clinic and in Tissue Engineering Applications
por: Ayerst, Bethanie I., et al.
Publicado: (2017) -
Microfluidic Screening Reveals Heparan Sulfate Enhances Human Mesenchymal Stem Cell Growth by Modulating Fibroblast Growth Factor‐2 Transport
por: Titmarsh, Drew M., et al.
Publicado: (2017) -
Age-Related Changes in the Inflammatory Status of Human Mesenchymal Stem Cells: Implications for Cell Therapy
por: Zhang, Ying, et al.
Publicado: (2021) -
Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine
por: Samsonraj, Rebekah M., et al.
Publicado: (2017) -
Heparin binding preference and structures in the fibroblast growth factor family parallel their evolutionary diversification
por: Li, Yong, et al.
Publicado: (2016)